Dual-Pathway Cancer Drug Combo Shows 27% Clinical Benefit Rate
Advanced cancer patients face diminishing treatment options as tumors develop resistance to conventional therapies, making novel combination approaches critica…
Found 1259 results for "cancer"
Advanced cancer patients face diminishing treatment options as tumors develop resistance to conventional therapies, making novel combination approaches critica…
Glioblastoma represents one of medicine's most formidable challenges, with median survival rarely exceeding 15 months despite aggressive treatment. The blood-b…
Pancreatic cancer remains one of the most lethal malignancies, with five-year survival rates below 10 percent. Finding effective first-line treatments that bal…
Cancer survivors carrying emotional wounds from childhood face a compounding burden that extends far beyond their oncological journey. The intersection of earl…
The pursuit of healthy aging takes on new urgency as evidence mounts that cardiovascular fitness during middle age fundamentally reshapes the trajectory of lat…
Cancer patients receiving advanced CAR-T cell immunotherapy can now breathe easier knowing that the treatment's most concerning side effects follow a predictab…
The longstanding debate over prostate cancer screening may have found its resolution through a precision medicine approach that dramatically improves the risk-…
Cancer patients with specific genetic mutations often watch promising immunotherapies fail where they succeed for others. This stark reality affects roughly on…
The foundational understanding of how adhesion G-protein coupled receptors initiate cellular responses may need revision, with implications for developing ther…
Naked mole-rats maintain extraordinarily stable gut microbiomes across three decades of life, contrasting sharply with laboratory mice that show extensive age-…
GLP-1 receptor agonists like semaglutide and tirzepatide cause weight loss that's 20-30% lean muscle mass, not just fat tissue. This muscle loss becomes partic…
New clinical evidence reveals that even light-to-moderate alcohol consumption significantly accelerates progression from fatty liver disease to cirrhosis and l…
Dasatinib plus quercetin (DQ) restored normal estrous cycles in 60% of mice with chemotherapy-induced ovarian failure, compared to just 15% recovery without tr…
Treatment resistance remains one of the most vexing challenges in colorectal cancer care, where certain tumor subtypes paradoxically thrive despite aggressive…
Cancer patients carrying RAS mutations—affecting one in five diagnoses—may soon benefit from dramatically expanded treatment options that move beyond the limit…
The prospect of avoiding chemotherapy while preparing lung cancer patients for surgery represents a significant shift in oncological practice. For the estimate…
Pancreatic ductal adenocarcinoma represents one of medicine's most formidable challenges, with survival rates that have barely improved despite decades of rese…
Cancer's ability to outsmart targeted therapies may hinge on an unexpected cellular waste disposal system that transforms neighboring tissue into metabolic gar…
College campuses represent critical intervention points for preventing skin cancer, as young adults consistently demonstrate poor UV protection habits during p…
The deadliest brain cancers may exploit the brain's own immune guardians to achieve their lethal spread. This discovery fundamentally challenges assumptions ab…